GLP-1 receptor agonists have rapidly become one of the most talked-about drug classes in modern medicine, and their growing use means pharmacists are increasingly on the front line of managing their risks and benefits. This session will provide a practical update on GLP-1 RAs for pharmacists across all practice settings.
This presentation will address the following learning objectives:
- Identify GLP-1 receptor agonists available in Australia and their approved indications.
- Evaluate post-marketing safety data for GLP-1 RAs from real-world use and its applicability to clinical practice.
- Describe evolving international guidance on perioperative and procedural management.
- Understand recent developments in international GLP-1 RA research and emerging therapeutic applications
- Discuss future developments in the pipeline for GLP-1 RA therapies.